Cargando…

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey

BACKGROUND: Chronic cough, defined as daily cough for at least 8 weeks, negatively affects quality of life and work productivity and increases healthcare resource utilisation. We aimed to determine the prevalence and burden of chronic cough in the UK. METHODS: Study participants were general populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGarvey, Lorcan, Morice, Alyn H., Martin, Ashley, Li, Vicky W., Doane, Michael J., Urdaneta, Eduardo, Schelfhout, Jonathan, Ding, Helen, Fonseca, Eileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350679/ https://www.ncbi.nlm.nih.gov/pubmed/37465559 http://dx.doi.org/10.1183/23120541.00157-2023

Ejemplares similares

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
por: Morice, Alyn H., et al.
Publicado: (2021)

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023)

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
por: Smith, Jaclyn A., et al.
Publicado: (2022)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020)

Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Combating cough
por: Morice, Alyn H
Publicado: (2016)

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
por: Smith, Jaclyn A., et al.
Publicado: (2019)

COUGH: consolidating a mature field for the next 5 years
por: Chung, Kian Fan, et al.
Publicado: (2011)

Chronic cough hypersensitivity syndrome
por: Morice, Alyn H
Publicado: (2013)

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
por: Friedrich, Christian, et al.
Publicado: (2023)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
por: Dicpinigaitis, Peter V., et al.
Publicado: (2023)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
por: Ludbrook, Valerie J., et al.
Publicado: (2021)

Chronic cough in Germany: results from a general-population survey
por: Virchow, J. Christian, et al.
Publicado: (2022)

Cough hypersensitivity and chronic cough
por: Chung, Kian Fan, et al.
Publicado: (2022)

The Cough Reflex: The Janus of Respiratory Medicine
por: Sykes, Dominic L., et al.
Publicado: (2021)

Changing the paradigm for cough: does 'cough hypersensitivity' aid our understanding?
por: Song, Woo-Jung, et al.
Publicado: (2014)

Adverse perception of cough in patients with severe asthma: a discrete choice experiment
por: Holmes, Joshua, et al.
Publicado: (2023)

Chronic cough associated with Crohn's disease
por: Faruqi, Shoaib, et al.
Publicado: (2010)

The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2023)

The Emerging Role of The Eosinophil and Its Measurement in Chronic Cough
por: Sadeghi, Mahboobeh H., et al.
Publicado: (2017)

Cough Hypersensitivity Syndrome: A Few More Steps Forward
por: Song, Woo-Jung, et al.
Publicado: (2017)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough
por: Molassiotis, Alex, et al.
Publicado: (2010)

Prevalence of psychomorbidity among patients with chronic cough
por: McGarvey, Lorcan PA, et al.
Publicado: (2006)

The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma
por: Natarajan, Sushiladevi, et al.
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2022)

Fundoplication in chronic intractable cough
por: Faruqi, Shoaib, et al.
Publicado: (2012)

Anatomy and Neurophysiology of Cough: CHEST Guideline and Expert Panel Report
por: Canning, Brendan J., et al.
Publicado: (2014)

The automatic recognition and counting of cough
por: Barry, Samantha J, et al.
Publicado: (2006)

Acute and chronic cough
por: McGarvey, L.P.A., et al.
Publicado: (2004)

Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring
por: Zhang, Mengru, et al.
Publicado: (2022)

Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis
por: Faruqi, Shoaib, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_stn46fgenqdh0l7djcnavqo7i4